You are here

Members

CEO Roundtable on Cancer Members

    Alexandria Real Estate Equities, Inc.
 Amgen, Inc.
    Amneal Pharmaceuticals
 Astellas Pharma Inc.
 AstraZeneca
 Bayer HealthCare Pharmaceuticals Inc.
 Boehringer Ingelheim USA Corporation
    Bristol-Myers Squibb
 C-Change
 Celgene
    Cree
 Duke Health
 Eli Lilly and Company
 EMD Serono
    Evercore Partners
    Gurnet Point Capital
 Hatteras Venture Partners
 Helsinn Group
 Hogan Lovells US LLP
 Independence Blue Cross
 Johnson & Johnson
     Lenovo
 MD Anderson Cancer Center
    Merck & Co., Inc.
 Novartis
     Pappas Ventures
 Pfizer, Inc.
 Quest Diagnostics
 Quintiles Transnational
 RTI International
 Sanofi
 SAS
    Spencer Stuart
 State Farm Insurance Companies
 Takeda Oncology
    The MITRE Corporation
 U.S. Chamber of Commerce
 Valeant Pharmaceuticals International

 Gold Standard accredited organization

 

Honorary Members

The CEO Roundtable on Cancer is proud to recognize the efforts of the following individuals who have worked to advance the mission of the Roundtable and are, therefore, welcomed as Honorary Members:

  • David Brennan, Former CEO, AstraZeneca plc
  • Victor Dzau, M.D., President, National Academy of Medicine
  • Coach Mike Krzyzewski, Head Coach, Mens’ basketball, Duke University
  • Thomas Moran, Chairman, President and CEO, Mutual of America
  • Charles A. Sanders, M.D., Chairman, Foundation for the National Institutes of Health
  • Robert Wise, President, Alliance for Excellent Education

 

U.S. Government Organizations

The CEO Roundtable on Cancer is proud to work to fight cancer in collaboration with the following organizations within the United States Department of Health and Human Services:

US Department of Health and Human Services

  • National Institutes of Health (NIH)
  •  National Cancer Institute (NCI)
  • Food and Drug Administration (FDA)
  •  Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)

 Gold Standard accredited organization